v2.4.0.8

Derivative Instruments (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Summary of aggregate notional amount and estimated fair value of derivative instruments | The following table presents the fair values of the Company's derivative instruments for the following periods:
| As of December 28, 2013 |  | As of December 29, 2012
In thousands | Notional |  | Fair Value |  | Notional |  | Fair Value
Designated hedges: |  |  |  |  |  |  |
Hygiene Euro Contracts | $ | — |  |  | $ | — |  |  | $ | 22,554 |  |  | $ | (1,248 | )
Undesignated hedges: |  |  |  |  |  |  |
Bridge Loan Contract | — |  |  | — |  |  | — |  |  | — |
Hygiene Euro Contracts | — |  |  | — |  |  | — |  |  | — |
Healthcare Euro Contracts | — |  |  | — |  |  | — |  |  | — |
Total | $ | — |  |  | $ | — |  |  | $ | 22,554 |  |  | $ | (1,248 | )
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location | The following table represents the amount of (gain) or loss associated with derivative instruments in the Consolidated Statement of Operations:
In thousands | Successor |  |  | Predecessor
Fiscal Year Ended December 28, 2013 |  | Fiscal Year Ended December 29, 2012 |  | Eleven Months Ended December 31, 2011 |  |  | One Month Ended January 28, 2011
Designated hedges: |  |  |  |  |  |  |  |
Healthcare Euro Hedges | $ | — |  |  | $ | — |  |  | $ | — |  |  |  | $ | (29 | )
Healthcare Euro Contracts | — |  |  | — |  |  | (544 | ) |  |  | (118 | )
Hygiene Euro Contracts | (449 | ) |  | (2,559 | ) |  | 3,807 |  |  |  | — |
Undesignated hedges: |  |  |  |  |  |  |  |
Bridge Loan Contract | — |  |  | — |  |  | — |  |  |  | — |
Healthcare Euro Contracts | — |  |  | (147 | ) |  | 809 |  |  |  | — |
Hygiene Euro Contracts | $ | (799 | ) |  | $ | — |  |  | $ | — |  |  |  | $ | — |
Total | $ | (1,248 | ) |  | $ | (2,706 | ) |  | $ | 4,072 |  |  |  | $ | (147 | )

X
- Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 + Details
Name: | us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration